BioForce Nanosciences

About:

BioForce Nanosciences, Inc. develops and commercializes nanotech instruments, consumables, and applications for the life sciences.

Website: http://bioforcenano.com/

Twitter/X: BioForceNano

Top Investors: Societe Generale Asset Management

Description:

BioForce Nanosciences develops and commercializes nanotech instruments, consumables, and applications for the life sciences. It provides consumable support products for atomic force microscopy. BioForce Nanosciences’ flagship instrument platform, Nano eNabler, is a molecular printer that delivers liquids to surfaces such as silicon chips in droplets and offers researchers in industry and academia a practical solution to problems they encounter when developing ultraminiaturized devices and methods, and creates opportunities for further commercialization of nanotechnology. Its additional applications include printing proteins to guide neural cell growth, printing signaling proteins to study stem cell differentiation, inking of micro-stamps for soft lithography, and bio-functionalization of microfluidic devices. BioForce Nanosciences’ ViriChip technology is designed to be sensitive and specific enough to detect a variety of different pathogens, including environmental pathogens, pathogens relevant to biodefense, animal and plant viruses, and human disease agents. BioForce Nanosciences was founded in 2003 and is headquartered in Ames, Iowa.